Wearable Integration in Clinical Research: From Consumer Gadgets to Validated Instruments

The biggest limitation in clinical research is not funding or recruitment. It is data density. A blood draw captures one moment. A wearable captures every moment. At SoliVana, we are proving that consumer-grade wearables can meet clinical-grade standards — if you know how to validate them.

The Snapshot Problem

Traditional clinical trials rely on periodic assessments: a blood draw at baseline, a questionnaire at week 4, a follow-up at week 12. This produces snapshots — isolated data points separated by weeks of unknown physiological state. It is like trying to understand a movie by looking at three frames.

Continuous monitoring solves this. A wearable that records HRV, heart rate, skin temperature, and movement every few seconds creates a physiological movie — revealing patterns, trajectories, and responses that periodic assessments simply cannot capture.

Validation: The Critical Step

Not all wearables are created equal. Before integrating any device into Protocol NSR-2026, we subject it to a rigorous validation pipeline:

• Gold-standard comparison — wearable HRV is compared against a clinical 12-lead ECG and Polar H10 chest strap under controlled conditions
• Inter-device reliability — multiple units of the same device are worn simultaneously to assess manufacturing consistency
• Signal quality analysis — we quantify missing data, motion artifacts, and signal dropout rates across activities
• Algorithm transparency — we require manufacturers to disclose how metrics are calculated, not just what they output
• Longitudinal drift — devices are tested over 12-week periods to detect sensor degradation or calibration drift

What We Measure Continuously

Protocol NSR-2026 participants wear validated devices 24/7 for the full 12 weeks. Our continuous data stream includes:

• HRV (RMSSD, SDNN) — every 5 minutes during waking hours, every 15 minutes during sleep
• Heart rate — continuous, with activity-contextualized baselines
• Skin temperature — a proxy for circadian rhythm and thermoregulatory function
• Sleep stages — validated against polysomnography in a subset of participants
• Movement and activity — step count, activity intensity, and sedentary time
• Respiratory rate — derived from heart rate variability during rest
• Blood oxygen saturation (SpO₂) — continuous nocturnal monitoring

The AI Layer

Raw wearable data is noise without interpretation. Our AI pipeline transforms continuous streams into actionable insights:

• Anomaly detection — flags physiological events that deviate from individual baselines
• Protocol adherence tracking — verifies that participants are completing assigned interventions
• Response prediction — uses early-week data to forecast 12-week outcomes with increasing accuracy
• Personalized coaching — generates real-time recommendations based on current autonomic state

For the FDA

The FDA's digital health guidance is evolving. We are building our data infrastructure to meet emerging standards for Software as a Medical Device (SaMD) and Predetermined Change Control Plans (PCCP). Our goal is not merely to collect data — but to produce evidence that regulators, insurers, and clinicians can trust.